Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
26 Cards in this Set
- Front
- Back
Name the catecholamines.
|
Epinephrine, norepinephrine, dopamine, fenoldopam, isoproterenol and dobutamine
|
|
Describe the kinetics of catecholamines.
|
short t1/2 (minutes), degrated rapidly by COMT and MAO, catechol moiety prevents ready absorption and CNS penetration. Must be administered IV.
|
|
What is the receptor specificity for epinephrine?
|
none
|
|
What is the mechanism of action of epinephrine?
|
nonspecific agonist to b and a receptors: therefore activation of sympathetic nervous system and all concomitant effects + inotropic and chronotropic effects on heart via b1 R, vasoconstriction of vasculature via a1-R balanced by vasodilation via b2 (PVR may fall and it may increases coronary and cerebral blood flow), b2 activation of bronchilar smooth muscle relaxes airways
|
|
Clinical uses of epinephrine.
|
glaucoma (increase outflow), anaphylaxis, Hypotension, Heart Failure (HF)-ACLS, reduce local blood flow, severe asthma
|
|
Toxicity of epinephrine.
|
sympathetic excess (ex: arrythmias, hypertension, cerebral hemorrhage, tachycardia and anxiety)
|
|
Receptor specificity for norepinephrine.
|
a1=a2; b1>>b2
|
|
Mechanism of action for norepinephrine
|
similar to epinephrine, however, more specific effects on a1 and b1. é in PVR via a1. Less b2-R activation (less effect of bronchilar smooth muscle and less coronary blood vessel dilation). b1 (++) activation increases CO
|
|
Clinical use of norepinephrine?
|
hypotension, HF
|
|
Toxicity of norepinephrine?
|
same as epinephrine + reflex bradycardia increased risk of Cardiac ischemia (less coronary vessel dilation with increased CO inc. O2 demand)
|
|
Receptor specificity for dopamine?
|
D1=D2 >>>b>>>a
|
|
Mechanism of action of dopamine?
|
low dosess--potent dopamine receptor agonist--dilation of renal and coronary vascular beds, medium doses speeds heart rate (beta), high doses produces vasoconstriction (a-R), also causes release of catecholamines
|
|
Clinical uses of dopamine?
|
hypotension, HF, especially useful for cardiogenic and hypovolemic shock which are associated with low cardiac output and compromised renal function
|
|
Toxicity of dopamine?
|
same as epinephrine + reflex bradycardia increased risk of Cardiac ischemia (less coronary vessel dilation with increased CO inc. O2 demand)
|
|
Receptor specificity for fenoldopam?
|
D1>>D2
|
|
Mechanism of action of Fenoldopam?
|
related to dopamine, similar effects on D-R, stimulates a2 receptors, presynaptic sympathetic inhibition
|
|
Clinical uses of Fenoldopam?
|
hypertension (severe)
|
|
Toxicity of Fenoldopam?
|
same as epinephrine + reflex bradycardia increased risk of Cardiac ischemia (less coronary vessel dilation with increased CO inc. O2 demand)
|
|
Receptor specificity for Isoproterenol?
|
b1=b2 >>>>>>>a (Is bein)
|
|
MOA for Isoproterenol?
|
+ inotropy and chronotropy, vasodilation (lowers PVR)
|
|
Clinical use for Isoproterenol?
|
bradycardia (atropine-resistant) or heart block
|
|
Toxicity for Isoproterenol?
|
palpitations, tachycardia, headache, flushed skin, cardiac ischemia and arrhythmias
|
|
Receptor specificity for Dobutamine?
|
b1>b2>>>>>a
|
|
MOA for Dobutamine?
|
b1 agonist (+++) with mixed a-agonist/antagonist (+/-) activity (depends on enantiomeric form), more prominent inotropic and chronotropic effects (small change in PVR)
|
|
Clinical use for Dobutamine?
|
HF
|
|
Toxicity for Dobutamine?
|
palpitations, tachycardia, headache, flushed skin, cardiac ischemia and arrhythmias
|